REFERENCES
- Fromer L. Improving diagnosis and management of Alpha-1 antitrypsin deficiency in primary care: Translating knowledge into action. COPD 2009;7:191–197.
- Stoller JK, Smith P, Yang P, Physical and social impact of a-1-antitrypsin deficiency: results of a mail survey of the readership of a national newsletter. Cleve Clin J Med 1994;61:461– 467.
- Stoller, JK, Sandhaus, RA, Turino, G, Dickson, R, Rodgers, K, Strange, C. Delay in diagnosis of alpha-1 antitrypsin deficiency: a continuing problem. Chest 2005;128:1989–1994.
- American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med 2003;168:818–900.
- Alpha 1-Antitrypsin Deficiency Registry Study Group prepared by McElvaney NJ, Stoller JK, Buist AS, Prakash UBS, Brantly M, Schluchter M, Crystal RG, Baseline characteristics of enrollees in the National Heart, Lung and Blood Institute Registry of a1-Antitrypsin Deficiency. Chest 1997;111:394– 403.
- Eden E, Mitchell D, Mehlman B, Khouli H, Morris N, Grieco MJ, Turino, GT. Atopy, asthma, and emphysema in patients with severe α-1-antitrypysin deficiency. Am J Respir Crit Care Med 1997;156:68–74.
- Mayer AS, Stoller JK, Bartelson BB, Ruttenber AJ, Sandhaus RA, Newman LS. Occupational exposure risks in individuals with PiZZ alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med 2000:161;1–6.
- Alpha1-antitrypsin Deficiency Registry Study Group. Survival and FEV1 decline in individuals with severe deficiency of a-1 antitrypsin. Am J Respir Crit Care Med 1998;158:49– 59.
- Seersholm N, Wencker M, Banik N, Viskum K, Dirksen A, Kok-Jensen A, Konietzko N. Does alpha-1 antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary alpha-1 antitrypsin deficiency? Eur Respir J 1997;10:2260–2263.
- Dirksen A, Piitulainen E, Parr DG, Deng C, Wencker M, Shaker SB, Stockley RA. Exploring the role of CT densitometry: a randomized study of augmentation therapy in α1-antitrypsin deficiency. Eur Respir J 2009;33:1345–1353.
- Chapman KR, Stockley RA, Dawkins C, Wilkes MM, Navickis RJ. Augmentation therapy for α1 antitrypsin deficiency: a meta-analysis. COPD J Chron Obstruct Pulm Dis 2009; 6:177– 84.
- Schluchter MD, Stoller JK, Barker AF, Buist AS, Crystal RG, Donohue JF, Fallat RJ, Turino GM, Vriem CE, Wu MC for the a 1-antitrypsin deficiency registry study group. Feasibility of a clinical trial of augmentation therapy for a1-antitrypsin deficiency. Am J Resp Crit Care Med 2000;161:796–801.
- Sandhaus, RA, Turino, G, Stocks, J, Strange, C, Trapnell, B, Silverman, EK, Everett, SE, Stoller, JK. α1-Antitrypsin augmentation therapy for PI*MZ heterozygotes. Chest 2008;134:831– 834.